#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA873214	Functional	Concentration required to inhibit 50% growth of L1210 /1565 mutant mouse leukemia cell line was determined	Mus musculus	10	ALA1125013	cell-based format	Scientific Literature
2.	ALA700048	Functional	Inhibitory activity against L 1210 cell proliferation	Mus musculus	50	ALA1135828	cell-based format	Scientific Literature
3.	ALA700049	Functional	Compound was tested in vitro for growth inhibitory activity against murine L1210 leukemia cell line	Mus musculus	1	ALA1126561	cell-based format	Scientific Literature
4.	ALA700050	Functional	Tested in vitro inhibitory activity against murine L 1210 leukemia cells line	Mus musculus	2	ALA1126561	cell-based format	Scientific Literature
5.	ALA700051	Functional	Percent inhibition against cells in G 1 phase by the compound	Mus musculus	1	ALA1135828	cell-based format	Scientific Literature
6.	ALA700052	Functional	Percent inhibition against cells in G 1 phase by the compound at the dose 10 uM	Mus musculus	2	ALA1135828	cell-based format	Scientific Literature
7.	ALA700053	Functional	Percent inhibition against cells in G 1 phase by the compound at the dose 25 uM	Mus musculus	3	ALA1135828	cell-based format	Scientific Literature
8.	ALA700054	Functional	Percent inhibition against cells in G 1 phase by the compound at the dose 5 uM	Mus musculus	3	ALA1135828	cell-based format	Scientific Literature
9.	ALA702588	Functional	Compound was evaluated for cytotoxicity against L-1210 (AK-) cells, and concentration required to inhibit the growth of treated cells to 50% of untreated control.	Mus musculus	2	ALA1122762	cell-based format	Scientific Literature
10.	ALA702589	Functional	Compound was evaluated for cytotoxicity against L-1210 (AK-) cells, and concentration required to inhibit the growth of treated cells to 50% of untreated control.	Mus musculus	1	ALA1122762	cell-based format	Scientific Literature
11.	ALA702590	Functional	Compound was evaluated for cytotoxicity against L-1210 (AK-) cells, and concentration required to inhibit the growth of treated cells to 50% of untreated control.	Mus musculus	1	ALA1122762	cell-based format	Scientific Literature
12.	ALA702591	Functional	Cytotoxicity in vitro expressed as 50% reduction in cell number after a 3-day incubation, in murine leukemia L-1210 cell line	Mus musculus	25	ALA1126989	cell-based format	Scientific Literature
13.	ALA702592	Functional	Compound was evaluated for cytotoxicity against L-1210 cells, and concentration required to inhibit the growth of treated cells to 50% of untreated control.	Mus musculus	2	ALA1122762	cell-based format	Scientific Literature
14.	ALA702593	Functional	Cytotoxic activity against L-1210 parental cell line	Mus musculus	3	ALA1128855	cell-based format	Scientific Literature
15.	ALA702594	Functional	Cytotoxic activity against adriamycin (ADR) resistant L-1210 cell line	Mus musculus	2	ALA1128855	cell-based format	Scientific Literature
16.	ALA702595	Functional	cytotoxic activity against adriamycin (ADR) resistant L-1210 cell line	Mus musculus	1	ALA1128855	cell-based format	Scientific Literature
17.	ALA702596	Functional	cytotoxic activity against leukemia (L-1210) cancer cell line	Mus musculus	1	ALA1131509	cell-based format	Scientific Literature
18.	ALA704005	Functional	Antitumor activity against L-1210 leukemia cell line in BDF1 mice after injecting 0.05 mg/kg intraperitoneal dose	Mus musculus	1	ALA1125096	organism-based format	Scientific Literature
19.	ALA704006	Functional	Antitumor activity against L-1210 leukemia cell line in BDF1 mice after injecting 0.05 mg/kg ip dose	Mus musculus	1	ALA1124896	organism-based format	Scientific Literature
20.	ALA704007	Functional	Antitumor activity against L-1210 leukemia cell line in BDF1 mice after injecting 0.125 mg/kg intraperitoneal dose	Mus musculus	1	ALA1125096	organism-based format	Scientific Literature